Literature DB >> 16416237

Differing clinical manifestations of celiac disease transmitted by bone marrow transplantation.

Mark R Borgaonkar1, Peter R Duggan, Grenfell Adams.   

Abstract

Mesh:

Year:  2006        PMID: 16416237     DOI: 10.1007/s10620-006-3109-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  10 in total

Review 1.  AGA technical review on Celiac Sprue. American Gastroenterological Association.

Authors:  P J Ciclitira; A L King; J S Fraser
Journal:  Gastroenterology       Date:  2001-05       Impact factor: 22.682

Review 2.  Celiac disease: a progress report.

Authors:  Donald A Antonioli
Journal:  Mod Pathol       Date:  2003-04       Impact factor: 7.842

Review 3.  Current concepts of celiac disease pathogenesis.

Authors:  D Schuppan
Journal:  Gastroenterology       Date:  2000-07       Impact factor: 22.682

4.  Celiac disease transmitted by allogeneic non-T cell-depleted bone marrow transplantation.

Authors:  M J Bargetzi; A Schönenberger; A Tichelli; R Fried; G Cathomas; E Signer; B Speck; A Gratwohl
Journal:  Bone Marrow Transplant       Date:  1997-10       Impact factor: 5.483

Review 5.  Autoimmune diseases and autoimmunity post-bone marrow transplantation.

Authors:  Y Sherer; Y Shoenfeld
Journal:  Bone Marrow Transplant       Date:  1998-11       Impact factor: 5.483

6.  Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study.

Authors:  Alessio Fasano; Irene Berti; Tania Gerarduzzi; Tarcisio Not; Richard B Colletti; Sandro Drago; Yoram Elitsur; Peter H R Green; Stefano Guandalini; Ivor D Hill; Michelle Pietzak; Alessandro Ventura; Mary Thorpe; Debbie Kryszak; Fabiola Fornaroli; Steven S Wasserman; Joseph A Murray; Karoly Horvath
Journal:  Arch Intern Med       Date:  2003-02-10

Review 7.  Coeliac disease: dissecting a complex inflammatory disorder.

Authors:  Ludvig M Sollid
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

8.  A high frequency of the A30, B18, DR3, DRw52, DQw2 extended haplotype in Sardinian celiac disease patients: further evidence that disease susceptibility is conferred by DQ A1*0501, B1*0201.

Authors:  M Congia; F Frau; R Lampis; R Frau; R Mele; F Cucca; F Muntoni; S Porcu; F Boi; L Contu
Journal:  Tissue Antigens       Date:  1992-02

9.  Prevalence of Celiac disease among children in Finland.

Authors:  Markku Mäki; Kirsi Mustalahti; Jorma Kokkonen; Petri Kulmala; Mila Haapalahti; Tuomo Karttunen; Jorma Ilonen; Kaija Laurila; Ingrid Dahlbom; Tony Hansson; Peter Höpfl; Mikael Knip
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

Review 10.  Coeliac disease.

Authors:  Peter H R Green; Bana Jabri
Journal:  Lancet       Date:  2003-08-02       Impact factor: 79.321

  10 in total
  3 in total

1.  National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage and dysfunction.

Authors:  Michael L Nieder; George B McDonald; Aiko Kida; Sangeeta Hingorani; Saro H Armenian; Kenneth R Cooke; Michael A Pulsipher; K Scott Baker
Journal:  Biol Blood Marrow Transplant       Date:  2011-10-01       Impact factor: 5.742

2.  Celiac disease resolution after allogeneic bone marrow transplantation is associated with absence of gliadin-specific memory response by donor-derived intestinal T-cells.

Authors:  Shomron Ben-Horin; Sylvie Polak-Charcon; Iris Barshack; Orit Picard; Ella Fudim; Miri Yavzori; Camila Avivi; Corine Mardoukh; Avichai Shimoni; Yehuda Chowers; Yaakov Maor
Journal:  J Clin Immunol       Date:  2013-10-20       Impact factor: 8.317

3.  Celiac disease presented after autologous bone marrow transplantation for acute myelogenous leukemia.

Authors:  Nasim Valizadeh; Kamran Shateri
Journal:  Indian J Med Paediatr Oncol       Date:  2013-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.